. 2021 Feb 15;2021:8867985. doi: 10.1155/2021/8867985

Table 3.

Results of hematological indices and serological (indirect and indirect) markers of liver fibrosis in examined patients.

Parameter (reference range)	ALC					NAFLD					Controls
Parameter (reference range)	x	s	me	min	max	x	s	me	min	max	x	s	me	min	max
PLT (130 − 400 × 10⁹/l)	119	81	93^∗∗∗∗	4	459	248	78	230^∗∗∗	8	506	293	62	297	160	400
MPV (8-11 fl)	9.12	1.51	8.8	6.6	14.4	7.94	0.95	7.85^∗∗∗∗	6.3	10.5	9.09	0.88	8.90	8	11
PDW (40-60%)	58.87	11.27	60.4^∗∗∗∗	20.4	95.9	54.91	7.98	54.75^∗∗	38	74.5	51.08	5.27	51.2	40.7	59.8
PCT (0.12-0.3%)	0.13	0.09	0.1^∗∗∗∗	0	0.57	0.2	0.08	0.19^∗∗	0.06	0.63	0.22	0.05	0.21	0.13	0.3
AAR	2.19	1.16	1.89^∗∗∗∗	0.18	7.57	1.03	0.55	0.91^∗	0.23	3.1	1.15	0.43	1.1	0.43	2.86
APRI	4.35	7.02	2.43^∗∗∗∗	0.15	68.38	0.81	1.04	0.48^∗∗∗∗	0.13	7.67	0.25	0.13	0.23	0.11	0.86
FIB-4	11.67	25.46	6.34^∗∗∗∗	0.69	287.59	1.92	1.63	1.57^∗∗∗∗	0.23	11.58	0.85	0.54	0.71	0.28	3.27
GPR	15.73	28.54	6.65^∗∗∗∗	0.18	188.71	2.76	5.57	0.54^∗∗∗∗	0.13	35.41	0.25	0.1	0.24	0.06	0.63
PICP (ng/ml)	63.32	31.53	60.53	6.15	161.12	52.14	27.56	46.08	10.10	147.27	58.26	37.39	44.18	0	202.89
PIIINP (ng/ml)	9.28	4.33	8.4^∗∗	2.43	28.65	11.41	3.99	11.00	2.18	25.35	11.07	5.61	10.25	4.35	43.63
PDGF-AB (pg/ml)	18280.47	806.06	17343.71^∗∗∗	1925.68	42823.84	26858.68	7335.09	26682.83	10821.02	49808.07	23579.28	10068.8	25623.2	1638.2	47758.7
TGF-α (pg/ml)	24	45.33	13.77^∗∗∗∗	0.872	507.09	17.89	19.18	12.09^∗∗∗∗	1.39	142.63	28.44	17.21	24.59	1.31	93.55
Laminin (ng/ml)	976.34	705.29	832.06^∗	101.933	3301.00	48	230.24	375.23^∗∗∗∗	72.87	1335.92	718.24	386.1	663.27	140.88	1813.88

^∗ p < 0.05, ^∗∗p < 0.01, ^∗∗∗p < 0.001, ^∗∗∗∗p < 0.0001.